Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Availability and cost of extracorporeal treatments for poisonings and other emergency indications: A worldwide survey

dc.contributor.authorBouchard, Josee
dc.contributor.authorLavergne, Valery
dc.contributor.authorRoberts, Darren
dc.contributor.authorCormier, Monique
dc.contributor.authorMorissette, Genevieve
dc.contributor.authorGhannoum, Marc
dc.date.accessioned2020-12-20T20:51:44Z
dc.date.available2020-12-20T20:51:44Z
dc.date.issued2017
dc.date.updated2020-11-23T10:14:28Z
dc.description.abstractBackground: Extracorporeal treatments (ECTRs) are used for different conditions, including replacement of organ function and poisoning. Current recommendations for ECTRs in various poisonings suggest that intermittent haemodialysis (IHD) is the most efficient technique. However, the practicality of these recommendations is poorly defined in view of limited information on availability and cost worldwide. Methods: A survey invitation to an Internet-based questionnaire was emailed between January 2014 and March 2015 to members of international societies to determine the availability, time to initiation and cost of ECTRs (including filters, dialysate, catheter, anticoagulant and nursing/physician salary). The median cost ratio of every ECTR compared with IHD performed in the same institution were presented. Results: The view rate was estimated at 28.1% (2532/9000), the participation rate was 40.1% (1015/2532) and the completion rate was 16.0% (162/1015). Respondents originated from 89 countries, and nearly three-fourths practiced in a tertiary care centre. A total of 162 respondents provided sufficient data for in-depth analysis. IHD was the most available acute ECTR (96.9%), followed by therapeutic plasma exchange (TPE; 68.3%), continuous renal replacement therapy (CRRT; 62.9%), peritoneal dialysis (PD; 44.8%), haemoperfusion (HP; 30.9%) and liver support devices (LSDs; 14.7%). IHD, CRRT and HP were the shortest to initiate (median60 min). The median cost ratios of each ECTR compared with IHD were 1.7 for CRRT and HP, 2.8 for TPE, 6.5 for LSDs and 1.4 for PD (P<0.001 for all). The median cost ratio of a 4-h IHD treatment compared with 1 day in the intensive care unit was 0.6 (P 0.2). Conclusions: IHD appears to be the most widely available ECTR worldwide and is at least 30% less expensive than other ECTRs. The superior efficacy of IHD for enhanced elimination, added to its lower cost and wider availability, strengthens its preference as the ECTR of choice in most cases of acute poisoning
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn0931-0509
dc.identifier.urihttp://hdl.handle.net/1885/217871
dc.language.isoen_AUen_AU
dc.publisherOxford University Press
dc.sourceNephrology Dialysis Transplantation
dc.titleAvailability and cost of extracorporeal treatments for poisonings and other emergency indications: A worldwide survey
dc.typeJournal article
local.bibliographicCitation.issue4
local.bibliographicCitation.lastpage706
local.bibliographicCitation.startpage699
local.contributor.affiliationBouchard, Josee, University of Montreal
local.contributor.affiliationLavergne, Valery, University of Montreal
local.contributor.affiliationRoberts, Darren, College of Health and Medicine, ANU
local.contributor.affiliationCormier, Monique, University of Montreal
local.contributor.affiliationMorissette, Genevieve, University of Montreal
local.contributor.affiliationGhannoum, Marc, University of Montreal
local.contributor.authoruidRoberts, Darren, u4070191
local.description.notesImported from ARIES
local.identifier.absfor110202 - Haematology
local.identifier.ariespublicationa383154xPUB7013
local.identifier.citationvolume32
local.identifier.doi10.1093/ndt/gfw456
local.identifier.scopusID2-s2.0-85019110406
local.identifier.thomsonID000401057000018
local.type.statusPublished Version

Downloads